1. IL-17A exacerbates caspase-12-dependent neuronal apoptosis following ischemia through the Src-PLCγ-calpain pathway.
- Author
-
Wang H, Han S, Xie J, Zhao R, Li S, and Li J
- Subjects
- Animals, Mice, Male, src-Family Kinases metabolism, src-Family Kinases antagonists & inhibitors, Infarction, Middle Cerebral Artery pathology, Cells, Cultured, Calpain metabolism, Calpain antagonists & inhibitors, Interleukin-17 metabolism, Apoptosis physiology, Apoptosis drug effects, Phospholipase C gamma metabolism, Neurons metabolism, Neurons pathology, Neurons drug effects, Mice, Inbred C57BL, Brain Ischemia metabolism, Brain Ischemia pathology, Signal Transduction physiology, Signal Transduction drug effects, Caspase 12 metabolism
- Abstract
Interleukin-17 A (IL-17 A) contributes to inflammation and causes secondary injury in post-stroke patients. However, little is known regarding the mechanisms that IL-17 A is implicated in the processes of neuronal death during ischemia. In this study, the mouse models of middle cerebral artery occlusion/reperfusion (MCAO/R)-induced ischemic stroke and oxygen-glucose deprivation/reoxygenation (OGD/R)-simulated in vitro ischemia in neurons were employed to explore the role of IL-17 A in promoting neuronal apoptosis. Mechanistically, endoplasmic reticulum stress (ERS)-induced neuronal apoptosis was accelerated by IL-17 A activation through the caspase-12-dependent pathway. Blocking calpain or phospholipase Cγ (PLCγ) inhibited IL-17 A-mediated neuronal apoptosis under ERS by inhibiting caspase-12 cleavage. Src and IL-17 A are linked, and PLCγ directly binds to activated Src. This binding causes intracellular Ca
2+ flux and activates the calpain-caspase-12 cascade in neurons. The neurological scores showed that intracerebroventricular (ICV) injection of an IL-17 A neutralizing mAb decreased the severity of I/R-induced brain injury and suppressed apoptosis in MCAO mice. Our findings reveal that IL-17 A increases caspase-12-mediated neuronal apoptosis, and IL-17 A suppression may have therapeutic potential for ischemic stroke., Competing Interests: Declaration of competing interest The authors declare that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF